CorMedix (CRMD) Other Operating Expenses (2015 - 2026)
CorMedix (CRMD) posted Other Operating Expenses of -$4.1 million for Q4 2025, down 70.88% sequentially from -$2.4 million in Q3 2025, and up 75.19% YoY from -$2.3 million in Q4 2024.
CorMedix (CRMD) Other Operating Expenses (2015 - 2026) Analysis & Trends
CorMedix has reported Other Operating Expenses for 6 years, with the latest figure at -$4.1 million in Q4 2025.
- Quarterly Other Operating Expenses rose 75.19% year-over-year to -$4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (up 255.95% YoY) and the FY2025 annual result came in at -$6.5 million, down 264.92% from the prior year.
- Other Operating Expenses fell to -$4.1 million in Q4 2025 per CRMD's latest filing, from -$2.4 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $7.2 million in Q4 2023 and troughed at -$16.5 million in Q4 2024.
- A 3-year average of $1.3 million and a median of $3.3 million in 2023 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses plunged 328.04% in 2024, then soared 880.67% in 2025.
- Over 3 years, Other Operating Expenses stood at $7.2 million in 2023, then tumbled by 328.04% to -$16.5 million in 2024, then jumped by 75.19% to -$4.1 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$4.1 million, -$2.4 million, and $6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.65 Mn |
| Dec 31, 2025 | -4.10 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Dec 31, 2024 | -16.53 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 650,988.00 |
| Mar 31, 2024 | 6.34 Mn |
| Dec 31, 2023 | 7.25 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Dec 31, 2019 | -7.61 Mn |
| Dec 31, 2017 | -56,487.00 |
| Sep 30, 2017 | -1.97 Mn |
| Jun 30, 2017 | 1.85 Mn |
| Dec 31, 2015 | 3.75 Mn |
| Sep 30, 2015 | 4.71 Mn |
| Jun 30, 2015 | 4.15 Mn |